Latest news
BlossomHill, Latigo bloom on Nasdaq with oversubscribed IPOs - BioSpaceBioSpace · Mon, 10 Aug 2026 12:44:15 GMTBraveheart Bio’s $382M IPO for Heart Drug Leads a Big Week for Biotech IPOs - MedCity NewsMedCity News · Mon, 10 Aug 2026 03:12:34 GMTU.S. IPO Weekly Recap: August Kicks Off With Flurry Of Biotech IPOs - Seeking AlphaSeeking Alpha · Sat, 08 Aug 2026 04:30:00 GMTLatigo, BlossomHill cap busy week in biotech IPOs with nearly $500M haul - FirstWord PharmaFirstWord Pharma · Fri, 07 Aug 2026 17:52:10 GMTBiotech Stocks: The New Drugs That Could Fuel Big Gains - Barron'sBarron's · Fri, 07 Aug 2026 15:30:00 GMTBlossomHill, Latigo outshine IPO expectations with oversubscribed debuts - Fierce BiotechFierce Biotech · Fri, 07 Aug 2026 15:10:10 GMTLatigo IPO raises nearly $350M for pain drug development - BioPharma DiveBioPharma Dive · Fri, 07 Aug 2026 13:05:46 GMTNon-opioid painkiller developer Latigo (LTGO.US) seeks to ride the biotech IPO “boom”! Issuance priced at $18 per share, aiming to raise $346 million - BitgetBitget · Fri, 07 Aug 2026 08:51:08 GMT